Bloom Energy heads into the final week of June with a contradictory setup — the stock is up 14.6% on the week yet fell 6.9% on Tuesday alone, and options traders have turned more defensive than at any point in the past year.
The options signal is the sharpest data point right now. The put/call ratio hit 1.45 on June 23, its highest reading of the past 52 weeks, and more than three standard deviations above its 20-day mean of 1.19. That is not a routine hedge — it is the options market pricing in unusually heavy demand for downside protection, right after a week of strong gains. The stock closed at $321.98, having touched prices around $289 as recently as June 16. That kind of vertical move in five sessions, followed by a single-day reversal of nearly 7%, tends to generate exactly this kind of protective activity.
Short interest continues its patient grind higher, though it remains far from a mechanical squeeze. The short position has grown to 13.0% of the free float — up from 12.5% when the previous note flagged that shorts were sitting on their hands through the bounce. The 30-day build is now 17%, a persistent accumulation that has been running since early May. Yet the borrow market tells a story of almost no stress. Availability is extraordinarily loose at 1,527% — meaning there are roughly 15 shares available to borrow for every one already out on loan. That is dramatically tighter than a week ago (availability was above 2,000% on June 17 and above 3,000% in early June), but still one of the most open lending conditions in the universe. Cost to borrow has eased 18% on the week to just 0.35%. Shorts can add freely. They simply aren't being forced to cover. The contrast with the options market is explicit: options traders are rushing for protection while the short book quietly expands, neither side flinching.
The Street is broadly onside on the business but cautious on the price. Barclays raised its target to $276 on June 23, maintaining an Equal-Weight rating — a firm that has lifted its target twice in six weeks (from $177 to $254 in May, then to $276 now) yet still won't go above neutral. Bernstein initiated at Market Perform with a $276 target last week. The mean price target across the Street is $264.53, which is nearly 18% below where the stock is trading today. JP Morgan, which carries an Overweight, has its target at $267. Even the most bullish analyst with a published target (RBC at $335) is below the current price. That divergence between a stock at $322 and a consensus target of $264 warrants attention — the Street's targets were set after an April earnings beat that sent the stock up 22% in a day, and the stock has since run a further 15% beyond where most analysts thought fair value was. EPS momentum factor scores are extraordinary — in the 91st and 98th percentile on 30-day and 90-day windows — and the forward EPS trajectory is well above consensus from a year ago, but the PE multiple is now above 103x and EV/EBITDA above 81x. Growth is priced in.
Insider activity has been one-directional. Six executives sold shares in June — the COO, Chief Commercial Officer, Chief Legal Officer, and Chief Accounting Officer all sold on June 16, at prices around $289, collectively offloading over $3.3 million in stock. Director John Chambers sold 55,000 shares at $297.69 in late May for $16.4 million. The 90-day net share figure is technically positive (founder K.R. Sridhar received an 80,000-share award in May), but stripping out that non-cash award, the cash-sale pressure has been consistent and broad-based. No single trade is a signal on its own, but the pattern — multiple C-suite sellers at prices well below today's $322 — is worth noting as the stock hits new highs.
Earnings are scheduled for July 30. The last three prints produced moves of +7%, -9%, and +23% on the day. The most recent, in April, was followed by a 26% five-day gain. The next print falls just over five weeks away, and with the stock now trading above every analyst's published price target and options positioning at a 52-week defensive extreme, the setup heading into that date is the key dynamic to track.
See the live data behind this article on ORTEX.
Open BE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
